27 results on '"Kapiga, Saidi"'
Search Results
2. Efficacy of a Single, Brief Alcohol Reduction Intervention among Men and Women Living with HIV/AIDS and Using Alcohol in Kampala, Uganda: A Randomized Trial
- Author
-
Wandera, Bonnie, Tumwesigye, Nazarius Mbona, Nankabirwa, Joaniter Immaculate, Mafigiri, David Kaawa, Parkes-Ratanshi, Rosalind M, Kapiga, Saidi, Hahn, Judith, and Sethi, Ajay K
- Subjects
Biomedical and Clinical Sciences ,Clinical and Health Psychology ,Public Health ,Health Sciences ,Clinical Sciences ,Psychology ,Mental Health ,Alcoholism ,Alcohol Use and Health ,Behavioral and Social Science ,HIV/AIDS ,Clinical Research ,Substance Misuse ,Prevention ,Evaluation of treatments and therapeutic interventions ,6.1 Pharmaceuticals ,Good Health and Well Being ,Acquired Immunodeficiency Syndrome ,Adult ,Alcohol Drinking ,Counseling ,Female ,HIV Infections ,Humans ,Male ,Middle Aged ,Motivational Interviewing ,Uganda ,Africa ,alcohol ,brief interventions ,randomized trial - Abstract
We evaluated the efficacy of a brief motivational intervention (MI) counseling in reducing alcohol consumption among persons living with HIV/AIDS in Kampala, Uganda. Persons living with HIV/AIDS with Alcohol Use Disorders Identification Tool (AUDIT) score ≥3 points were randomized to either standardized positive prevention counseling alone or in combination with alcohol brief MI counseling. The mean change in AUDIT-C scores over 6 months was compared by treatment arm. The mean (standard deviation [SD]) AUDIT-C scores were 6.3 (2.3) and 6.8 (2.3) for control and MI arms ( P = .1) at baseline, respectively, and change in mean AUDIT-C score was not statistically different between arms over the 6 months ( P = .8). However, there was a statistically significant decrease in mean AUDIT-C score (-1.10; 95% confidence interval: -2.19 to -0.02, P = .046) among women in the MI arm. There was a nondifferential reduction in alcohol consumption overall, but MI appeared effective among women only. Studies with more than 1 counseling session and evaluation of gender differences in treatment response are needed.
- Published
- 2017
3. Contested or complementary healing paradigms? Women’s narratives of COVID-19 remedies in Mwanza, Tanzania
- Author
-
Mshana, Gerry, Mchome, Zaina, Aloyce, Diana, Peter, Esther, Kapiga, Saidi, and Stöckl, Heidi
- Published
- 2021
- Full Text
- View/download PDF
4. Plasma Cytokine Levels and Risk of HIV Type 1 (HIV-1) Transmission and Acquisition: A Nested Case-Control Study Among HIV-1–Serodiscordant Couples
- Author
-
Kahle, Erin M, Team, for the Partners in Prevention HSV HIV Transmission Study, Bolton, Michael, Hughes, James P, Donnell, Deborah, Celum, Connie, Lingappa, Jairam R, Ronald, Allan, Cohen, Craig R, de Bruyn, Guy, Fong, Youyi, Katabira, Elly, McElrath, M Juliana, Baeten, Jared M, Wald, Anna, Lingappa, Jairam, Magaret, Amalia, Corey, Lawrence, Coetzee, David, Fife, Kenneth, Were, Edwin, Essex, Max, Makhema, Joseph, Bukusi, Elizabeth, Cohen, Craig, Allen, Susan, Kanweka, William, Kapiga, Saidi, Manongi, Rachel, Farquhar, Carey, John-Stewart, Grace, Kiarie, James, Inambao, Mubiana, Farm, Orange, Delany-Moretlwe, Sinead, Rees, Helen, Gray, Glenda, McIntyre, James, and Mugo, Nelly Rwamba
- Subjects
Medical Microbiology ,Biomedical and Clinical Sciences ,Immunology ,Sexually Transmitted Infections ,Infectious Diseases ,HIV/AIDS ,Infection ,Good Health and Well Being ,Adult ,Africa South of the Sahara ,Case-Control Studies ,Cytokines ,Female ,HIV Infections ,HIV-1 ,Humans ,Male ,Risk Factors ,Sexual Partners ,Young Adult ,HIV-1 acquisition ,immune activation ,Africa ,Partners in Prevention HSV/HIV Transmission Study Team ,Biological Sciences ,Medical and Health Sciences ,Microbiology ,Biological sciences ,Biomedical and clinical sciences ,Health sciences - Abstract
BackgroundA heightened proinflammatory state has been hypothesized to enhance human immunodeficiency virus type 1 (HIV-1) transmission - both susceptibility of HIV-1-exposed persons and infectiousness of HIV-1-infected persons.MethodsUsing prospective data from heterosexual African couples with HIV-1 serodiscordance, we conducted a nested case-control analysis to assess the relationship between cytokine concentrations and the risk of HIV-1 acquisition. Case couples (n = 120) were initially serodiscordant couples in which HIV-1 was transmitted to the seronegative partner during the study; control couples (n = 321) were serodiscordant couples in which HIV-1 was not transmitted to the seronegative partner. Differences in a panel of 30 cytokines were measured using plasma specimens from both HIV-1-susceptible and HIV-1-infected partners. Plasma was collected before seroconversion for cases.ResultsFor both HIV-1-infected and HIV-1-susceptible partners, cases and controls had significantly different mean responses in cytokine panels (P < .001, by the Hotelling T(2) test), suggesting a broadly different pattern of immune activation for couples in which HIV-1 was transmitted, compared with couples without transmission. Individually, log10 mean concentrations of interleukin 10 (IL-10) and CXCL10 were significantly higher for both HIV-1-susceptible and HIV-1-infected case partners, compared with HIV-1-susceptible and HIV-1-infected control partners (P < .01 for all comparisons). In multivariate analysis, HIV-1 transmission was significantly associated with elevated CXCL10 concentrations in HIV-1-susceptible partners (P = .001) and with elevated IL-10 concentrations in HIV-1-infected partners (P = .02).ConclusionsImmune activation, as measured by levels of cytokine markers, particularly elevated levels of IL-10 and CXCL1, are associated with increased HIV-1 susceptibility and infectiousness.
- Published
- 2015
5. Enabling the genomic revolution in Africa
- Author
-
Rotimi, Charles, Abayomi, Akin, Abimiku, Alash'le, Adabayeri, Victoria May, Adebamowo, Clement, Adebiyi, Ezekiel, Ademola, Adebowale D, Adeyemo, Adebowale, Adu, Dwomoa, Affolabi, Dissou, Agongo, Godfred, Ajayi, Samuel, Akarolo-Anthony, Sally, Akinyemi, Rufus, Akpalu, Albert, Alberts, Marianne, Alonso Betancourt, Orlando, Alzohairy, Ahmed Mansour, Ameni, Gobena, Amodu, Olukemi, Anabwani, Gabriel, Andersen, Kristian, Arogundade, Fatiu, Arulogun, Oyedunni, Asogun, Danny, Bakare, Rasheed, Balde, Naby, Baniecki, Mary Lynn, Beiswanger, Christine, Benkahla, Alia, Bethke, Lara, Boehnke, Micheal, Boima, Vincent, Brandful, James, Brooks, Andrew I, Brosius, Frank C, Brown, Chester, Bucheton, Bruno, Burke, David T, Burnett, Barrington G, Carrington-Lawrence, Stacy, Carstens, Nadia, Chisi, John, Christoffels, Alan, Cooper, Richard, Cordell, Heather, Crowther, Nigel, Croxton, Talishiea, de Vries, Jantina, Derr, Leslie, Donkor, Peter, Doumbia, Seydou, Duncanson, Audrey, Ekem, Ivy, El Sayed, Ahmed, Engel, Mark E, Enyaru, John CK, Everett, Dean, Fadlelmola, Faisal M, Fakunle, Eyitayo, Fischbeck, Kenneth H, Fischer, Anne, Folarin, Onikepe, Gamieldien, Junaid, Garry, Robert F, Gaseitsiwe, Simani, Gbadegesin, Rasheed, Ghansah, Anita, Giovanni, Maria, Goesbeck, Parham, Gomez-Olive, F Xavier, Grant, Donald S, Grewal, Ravnit, Guyer, Mark, Hanchard, Neil A, Happi, Christian T, Hazelhurst, Scott, Hennig, Branwen J, Hertz-, Christiane, Fowler, Hide, Winston, Hilderbrandt, Friedhelm, Hugo-Hamman, Christopher, Ibrahim, Muntaser E, James, Regina, Jaufeerally-Fakim, Yasmina, Jenkins, Carolyn, Jentsch, Ute, Jiang, Pan-Pan, Joloba, Moses, Jongeneel, Victor, Joubert, Fourie, Kader, Mukthar, Kahn, Kathleen, Kaleebu, Pontiano, Kapiga, Saidi H, Kassim, Samar Kamal, Kasvosve, Ishmael, Kayondo, Jonathan, and Keavney, Bernard
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Genetics ,Clinical Sciences ,Medical Microbiology ,Human Genome ,Cancer ,Infectious Diseases ,HIV/AIDS ,Clinical Research ,Biotechnology ,Rare Diseases ,2.6 Resources and infrastructure (aetiology) ,Aetiology ,Infection ,Good Health and Well Being ,Africa ,Disease ,England ,Genetics ,Medical ,Genome-Wide Association Study ,Genomics ,Health ,Humans ,National Institutes of Health (U.S.) ,United States ,H3Africa Consortium ,General Science & Technology - Abstract
H3Africa is developing capacity for health-related genomics research in Africa
- Published
- 2014
6. Characteristics of HIV-1 Discordant Couples Enrolled in a Trial of HSV-2 Suppression to Reduce HIV-1 Transmission: The Partners Study
- Author
-
Lingappa, Jairam R, Kahle, Erin, Mugo, Nelly, Mujugira, Andrew, Magaret, Amalia, Baeten, Jared, Bukusi, Elizabeth A, Cohen, Craig R, Katabira, Elly, Ronald, Allan, Kiarie, James, Farquhar, Carey, Stewart, Grace John, Makhema, Joseph, Essex, M, Were, Edwin, Fife, Kenneth, deBruyn, Guy, Gray, Glenda, McIntyre, James, Manongi, Rachel, Kapiga, Saidi, Coetzee, David, Allen, Susan, Inambao, Mubiana, Kayitenkore, Kayitesi, Karita, Etienne, Kanweka, William, Delany, Sinead, Rees, Helen, Vwalika, Bellington, Coombs, Robert W, Morrow, Rhoda, Whittington, William, Corey, Lawrence, Wald, Anna, and Celum, Connie
- Subjects
Biomedical and Clinical Sciences ,Public Health ,Clinical Sciences ,Health Sciences ,Medical Microbiology ,Clinical Trials and Supportive Activities ,Infectious Diseases ,HIV/AIDS ,Clinical Research ,Prevention ,Sexually Transmitted Infections ,6.1 Pharmaceuticals ,Evaluation of treatments and therapeutic interventions ,Infection ,Good Health and Well Being ,Acyclovir ,Adult ,Africa ,Antiviral Agents ,CD4 Lymphocyte Count ,Cohort Studies ,Female ,Follow-Up Studies ,HIV Infections ,HIV-1 ,Herpes Genitalis ,Herpesvirus 2 ,Human ,Heterosexuality ,Humans ,Male ,RNA ,Viral ,Sexual Partners ,Sexually Transmitted Diseases ,Partners HSV-2/HIV-1 Transmission Study Team ,General Science & Technology - Abstract
BackgroundThe Partners HSV-2/HIV-1 Transmission Study (Partners Study) is a phase III, placebo-controlled trial of daily acyclovir for genital herpes (HSV-2) suppression among HIV-1/HSV-2 co-infected persons to reduce HIV-1 transmission to their HIV-1 susceptible partners, which requires recruitment of HIV-1 serodiscordant heterosexual couples. We describe the baseline characteristics of this cohort.MethodsHIV-1 serodiscordant heterosexual couples, in which the HIV-1 infected partner was HSV-2 seropositive, had a CD4 count >or=250 cells/mcL and was not on antiretroviral therapy, were enrolled at 14 sites in East and Southern Africa. Demographic, behavioral, clinical and laboratory characteristics were assessed.ResultsOf the 3408 HIV-1 serodiscordant couples enrolled, 67% of the HIV-1 infected partners were women. Couples had cohabitated for a median of 5 years (range 2-9) with 28% reporting unprotected sex in the month prior to enrollment. Among HIV-1 susceptible participants, 86% of women and 59% of men were HSV-2 seropositive. Other laboratory-diagnosed sexually transmitted infections were uncommon (500 relative to
- Published
- 2009
7. Sexuality, fertility and family planning characteristics of married women aged 15 to 19 years in Ethiopia, Nigeria and Tanzania: a comparative analysis of cross-sectional data
- Author
-
Atchison, Christina J., Cresswell, Jenny A., Kapiga, Saidi, Nsanya, Mussa Kelvin, Crawford, Emily E., Mussa, Mohammed, Bottomley, Christian, Hargreaves, James R., and Doyle, Aoife M.
- Published
- 2019
- Full Text
- View/download PDF
8. Risk Factors for HIV-1 Seroprevalence among Family Planning Clients in Dar es Salaam, Tanzania
- Author
-
Kapiga, Saidi H., Lyamuya, Eligius F., Vuylsteke, Bea, Spiegelman, Donna, Larsen, Ulla, and Hunter, David J.
- Published
- 2000
- Full Text
- View/download PDF
9. Women’s income and risk of intimate partner violence: secondary findings from the MAISHA cluster randomised trial in North-Western Tanzania
- Author
-
Abramsky, Tanya, Lees, Shelley, Stöckl, Heidi, Harvey, Sheila, Kapinga, Imma, Ranganathan, Meghna, Mshana, Gerry, and Kapiga, Saidi
- Published
- 2019
- Full Text
- View/download PDF
10. A cluster randomized controlled trial to assess the impact on intimate partner violence of a 10-session participatory gender training curriculum delivered to women taking part in a group-based microfinance loan scheme in Tanzania (MAISHA CRT01): study protocol
- Author
-
Harvey, Sheila, Lees, Shelley, Mshana, Gerry, Pilger, Daniel, Hansen, Christian, Kapiga, Saidi, and Watts, Charlotte
- Published
- 2018
- Full Text
- View/download PDF
11. Same habitus in new field? How mobile phone communication reproduces masculinities and gender inequality in intimate relationships in Mwanza, Tanzania.
- Author
-
Mshana, Gerry, Malibwa, Donati, Aloyce, Diana, Peter, Esther, Mchome, Zaina, Kapiga, Saidi, and Stöckl, Heidi
- Subjects
CELL phones ,MASCULINITY ,GENDER role ,RECOGNITION (Psychology) ,INTIMACY (Psychology) ,INTERVIEWING ,FAMILIES ,VIOLENCE ,SEX distribution ,SOCIOECONOMIC factors ,GENDER ,INTIMATE partner violence ,COMMUNICATION ,INTERPERSONAL relations ,LOVE ,TRUST - Abstract
The use of mobile phones and other communication technologies is booming in low-income contexts. Yet there is lack of detailed analyses of their impact to social interactions, including intimate relationships between men and women and gender-based violence. Drawing on Bourdieu's concepts of habitus and field, we argue that mobile phones reproduce gender inequality and negative masculinities in these relationships. This happens through the diverse use of phones, and the interactive interface of the physical, electronic and social spaces within the broader social and economic context. We analyzed 48 in-depth interviews with men and women in Mwanza, Tanzania to explore how mobile phone use reproduces entrenched masculinities, gender norms, and power struggles in their daily lives and social interactions. Intimate partners navigate these complexities in several ways, including by creating 'private spaces' through their phones and concealing their communications. Men draw on negative masculinities to dominate their partner's phone use, while women engage social recognition and family custodianship to influence their partner's behaviour. These endeavours redefine concepts such as love and care, trust and faithfulness in the relationships. It is crucial to assess how technological advances are transforming intimate relationships and impacting gender-based violence in low-income countries. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
12. Human papillomavirus DNA detected in fingertip, oral and bathroom samples from unvaccinated adolescent girls in Tanzania
- Author
-
Houlihan, Catherine F, Baisley, Kathy, Bravo, Ignacio G, Pavón, Miguel A, Changalucha, John, Kapiga, Saidi, De Sanjosé, Silvia, Ross, David A, Hayes, Richard J, Watson-Jones, Deborah, London School of Hygiene and Tropical Medicine (LSHTM), Virostyle (MIVEGEC-Virostyle), Perturbations, Evolution, Virulence (PEV), Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Maladies infectieuses et vecteurs : écologie, génétique, évolution et contrôle (MIVEGEC), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud])-Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Recherche pour le Développement (IRD [France-Sud]), National Institute of Medical Research, Catalan Institute of Oncology, Infectious & Tropical Diseases, and Department of Epidemiology & Population Health
- Subjects
hpv ,Mouth ,Adolescent ,Epidemiology ,Papillomavirus Infections ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Tanzania ,Fingers ,Cross-Sectional Studies ,africa ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,DNA, Viral ,Vagina ,[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology ,Prevalence ,Humans ,Female ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Toilet Facilities ,epidemiology (general) ,Papillomaviridae - Abstract
International audience; 5 infections and cancer laboratory, cancer epidemiology research Program, catalan institute of Oncology (icO), Barcelona, Spain 6 ciBer-Onc, Hospitalet de llobregat, AbsTrACT Objective Human papillomavirus (HPV) Dna has been detected in vaginal samples from adolescent girls who report no previous sex and, in high-income settings, from fingertips, raising the possibility of non-sexual transmission. no such studies originate from east africa which bears among the highest cervical cancer incidence and HPV prevalence worldwide. HPV-related oral cancer incidence is increasing, but oral HPV prevalence data from east africa are limited. We aimed to describe the HPV Dna prevalence in genital and non-genital sites and in the bathroom of unvaccinated adolescent girls, and examine genotype concordance between sites. Methods We nested a cross-sectional study of HPV in genital and extragenital sites within a cohort study of vaginal HPV acquisition. Unvaccinated girls age 16-18 years in tanzania, who reported ever having had sex, were consented, enrolled and tested for the presence of HPV Dna in vaginal samples collected using self-administered swabs, oral samples collected using an oral rinse, and on fingertips and bathroom surfaces collected using a cytobrush. results Overall, 65 girls were enrolled and 23 (35%, 95% ci 23% to 47%) had detectable vaginal HPV. adequate (β-globin positive) samples were collected from 36 girls' fingertips and HPV was detected in 7 (19%, 95% ci 6% to 33%). 63 girls provided adequate oral samples, 4 (6%, 95% ci 0% to 13%) of which had HPV Dna detected. in bathroom samples from 58 girls, 4 (7%, 95% ci 0% to 14%) had detectable HPV Dna. Of the 11 girls with extragenital HPV, six had the same genotype in >1 site. Conclusion We found a high prevalence of HPV in non-genital sites in adolescent girls and in their bathrooms, in this region with a high cervical cancer incidence. concordance of genotypes between sites supports the possibility of autoinoculation.
- Published
- 2019
13. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania
- Author
-
Quentin Wilm, Terris-Prestholt Fern, Changalucha John, Soteli Selephina, Edmunds W John, Hutubessy Raymond, Ross David A, Kapiga Saidi, Hayes Richard, and Watson-Jones Deborah
- Subjects
Africa ,costs and cost analysis ,economics papillomavirus vaccines ,uterine cervical neoplasms ,Medicine - Abstract
Abstract Background Cervical cancer is the leading cause of female cancer-related deaths in Tanzania. Vaccination against human papillomavirus (HPV) offers a new opportunity to control this disease. This study aimed to estimate the costs of a school-based HPV vaccination project in three districts in Mwanza Region (NCT ID: NCT01173900), Tanzania and to model incremental scaled-up costs of a regional vaccination program. Methods We first conducted a top-down cost analysis of the vaccination project, comparing observed costs of age-based (girls born in 1998) and class-based (class 6) vaccine delivery in a total of 134 primary schools. Based on the observed project costs, we then modeled incremental costs of a scaled-up vaccination program for Mwanza Region from the perspective of the Tanzanian government, assuming that HPV vaccines would be delivered through the Expanded Programme on Immunization (EPI). Results Total economic project costs for delivering 3 doses of HPV vaccine to 4,211 girls were estimated at about US$349,400 (including a vaccine price of US$5 per dose). Costs per fully-immunized girl were lower for class-based delivery than for age-based delivery. Incremental economic scaled-up costs for class-based vaccination of 50,290 girls in Mwanza Region were estimated at US$1.3 million. Economic scaled-up costs per fully-immunized girl were US$26.41, including HPV vaccine at US$5 per dose. Excluding vaccine costs, vaccine could be delivered at an incremental economic cost of US$3.09 per dose and US$9.76 per fully-immunized girl. Financial scaled-up costs, excluding costs of the vaccine and salaries of existing staff were estimated at US$1.73 per dose. Conclusions Project costs of class-based vaccination were found to be below those of age-based vaccination because of more eligible girls being identified and higher vaccine uptake. We estimate that vaccine can be delivered at costs that would make HPV vaccination a very cost-effective intervention. Potentially, integrating HPV vaccine delivery with cost-effective school-based health interventions and a reduction of vaccine price below US$5 per dose would further reduce the costs per fully HPV-immunized girl.
- Published
- 2012
- Full Text
- View/download PDF
14. Social space and alcohol use initiation among youth in northern Tanzania.
- Author
-
Osaki, Haika, Mshana, Gerry, Mbata, Doris, Kapiga, Saidi, and Changalucha, John
- Subjects
YOUTH & alcohol ,ALCOHOL drinking ,SOCIAL space ,DISEASE prevalence ,YOUNG women ,SUBSTANCE abuse - Abstract
Introduction: Alcohol use is a key risk factor for disease worldwide. Consumption of alcohol is increasing in sub Saharan Africa, where youth are already at high risk of HIV due to its high prevalence in the region. Studies show that youth begin drinking alcohol early; however, there is a need to further explore the initiation of alcohol use in order to design appropriate interventions in this population. Methods: We conducted a qualitative study with youth in Mwanza and Kilimanjaro regions in Tanzania to explore alcohol consumption among youth. Participants were a purposive sample of youth aged 15–24 composed of secondary school and college students, and formal and informal sector employees. We conducted 35 in-depth interviews using a semi-structured guide to understand youth’s personal experiences with alcohol consumption. Two social scientists conducted a multi stage, inductive analysis of the data. Findings: Alcohol consumption was reported to mainly start during adolescence, although in some cases it started as early as at 10 years of age. Young women reported drinking less, and initiated drinking later compared to males. Social space assumed a primary role in alcohol initiation. The social environment and influence of important social actors were key aspects of youth’s social space. Youth reported starting to consume alcohol at home, social events and in stressful environments with key influencers being parents, relatives, peers and intimate partners. Conclusions: Our findings show that the social space (social environment and interactions) plays an important role in influencing youth initial consumption of alcohol. Interventions addressing alcohol initiation among the population need to address the social spaces where initiation takes place and engage the significant actors in these spaces. There is need to further explore underlying societal drinking norms to better understand how they shape social environments and young people’s initiation of alcohol use. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
15. A cross-sectional analysis of infection among heterosexual HIV-1 serodiscordant African couples.
- Author
-
Bochner, Aaron F., Baeten, Jared M., Rustagi, Alison S., Nakku-Joloba, Edith, Lingappa, Jairam R., Mugo, Nelly R., Bukusi, Elizabeth A., Kapiga, Saidi, Delany-Moretlwe, Sinead, Celum, Connie, Barnabas, Ruanne V., and Partners in Prevention HSV/HIV Transmission Study and Partners PrEP Study Teams
- Subjects
PREVENTION of communicable diseases ,HIV prevention ,PREVENTION of pregnancy complications ,HIV infection epidemiology ,COMMUNICABLE disease epidemiology ,CIRCUMCISION ,COMPARATIVE studies ,DNA ,HETEROSEXUALITY ,HIV ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,PREGNANCY complications ,TRICHOMONAS vaginalis ,PROTOZOA ,RESEARCH ,RESEARCH funding ,HUMAN sexuality ,EVALUATION research ,DISEASE prevalence ,CROSS-sectional method ,HIV seroconversion ,SEXUAL partners ,HIV seronegativity ,PREVENTION ,DIAGNOSIS ,INFECTIOUS disease transmission - Abstract
Objectives: Trichomonas vaginalis is the most prevalent curable STI worldwide and has been associated with adverse health outcomes and increased HIV-1 transmission risk. We conducted a cross-sectional analysis among couples to assess how characteristics of both individuals in sexual partnerships are associated with the prevalence of male and female T. vaginalis infection.Methods: African HIV-1 serodiscordant heterosexual couples were concurrently tested for trichomoniasis at enrolment into two clinical trials. T. vaginalis testing was by nucleic acid amplification or culture methods. Using Poisson regression with robust standard errors, we identified characteristics associated with trichomoniasis.Results: Among 7531 couples tested for trichomoniasis, 981 (13%) couples contained at least one infected partner. The prevalence was 11% (n=857) among women and 4% (n=319) among men, and most infected individuals did not experience signs or symptoms of T. vaginalis. Exploring concordance of T. vaginalis status within sexual partnerships, we observed that 61% (195/319) of T. vaginalis-positive men and 23% (195/857) of T. vaginalis-positive women had a concurrently infected partner. In multivariable analysis, having a T. vaginalis-positive partner was the strongest predictor of infection for women (relative risk (RR) 4.70, 95% CI 4.10 to 5.38) and men (RR 10.09, 95% CI 7.92 to 12.85). For women, having outside sex partners, gonorrhoea, and intermediate or high Nugent scores for bacterial vaginosis were associated with increased risk of trichomoniasis, whereas age 45 years and above, being married, having children and injectable contraceptive use were associated with reduced trichomoniasis risk. Additionally, women whose male partners were circumcised, had more education or earned income had lower risk of trichomoniasis.Conclusions: We found that within African HIV-1 serodiscordant heterosexual couples, the prevalence of trichomoniasis was high among partners of T. vaginalis-infected individuals, suggesting that partner services could play an important role identifying additional cases and preventing reinfection. Our results also suggest that male circumcision may reduce the risk of male-to-female T. vaginalis transmission. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
16. Hazardous alcohol consumption is not associated with CD4+ T-cell count decline among PLHIV in Kampala Uganda: A prospective cohort study.
- Author
-
Wandera, Bonnie, Tumwesigye, Nazarius M., Nankabirwa, Joaniter I., Kambugu, Andrew D., Mafigiri, David K., Kapiga, Saidi, and Sethi, Ajay K.
- Subjects
ALCOHOL drinking ,T cells ,COHORT analysis ,DISEASES ,HIV-positive persons - Abstract
Introduction: There is limited data on the effects of alcohol on immunological response among persons living with HIV (PLHIV) in sub-Saharan Africa. We assessed the relationship between hazardous alcohol use and CD4+ T-cell count, among PLHIV in Uganda. Methods: PLHIV aged ≥ 18 years were enrolled in a cohort study at the Infectious diseases clinic Kampala, Uganda. Alcohol consumption was assessed at enrolment (baseline) and 6 monthly thereafter using the alcohol use disorders identification test (AUDIT). The CD4+ T-cell counts, assessed at baseline and over the next 12 months were compared between alcohol use strata, using linear mixed effects regression. Using longitudinal mediation analysis methods, we estimated the effect of alcohol induced ART non-adherence on CD4+ T-cell count. Results: Of the 1566 participants enrolled, 863(44.1%) were non-alcohol users (AUDIT score = 0), 433(27.7%) were non-hazardous (AUDIT score 1–7) alcohol users while 270 (17.2%) were hazardous (AUDIT score ≥ 8) alcohol users. The overall median (IQR) baseline CD4+ T-cell count was 356 (243–516) cells/μl. There were no differences in the median baseline CD4+ T-cell count between hazardous and non-hazardous alcohol users compared to non-alcohol users in both the non-ART (p = 0.43) and ART group (p = 0.77). The mean CD4+ T-cell count over 12 months was not different between hazardous alcohol users and non-alcohol users (non-ART group p = 0.88 and ART group p = 0.62), nor between non-hazardous alcohol users and non-alcohol users (and non-ART group p = 0.66 and ART group p = 0.20). Alcohol use was not associated with a significant natural direct effect on CD4
+ T-cell count (1.37 95%CI [-1.78, 4.52] cells/μl, p = 0.39) but had a statistically significant natural indirect effect on reduction of CD4+ T-cell count (-0.91 cells/μl [-1.36, -0.45], p < 0.001) mediated through ART non-adherence. Conclusion: Hazardous alcohol use among PLHIV was not directly associated with lower CD4+ T-cell count but had a significant natural indirect effect on CD4+ T-cell count mediated through ART non-adherence. Among PLHIV with lower than expected CD4+ T-cell count, alcohol consumption should be excluded as an underlying factor for non-adherence to ART and any interventions targeting alcohol use should tackle possible ART non-adherence. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
17. Prevalence of intimate partner violence and abuse and associated factors among women enrolled into a cluster randomised trial in northwestern Tanzania.
- Author
-
Kapiga, Saidi, Harvey, Sheila, Muhammad, Abdul Khalie, Stöckl, Heidi, Mshana, Gerry, Hashim, Ramadhan, Hansen, Christian, Lees, Shelley, and Watts, Charlotte
- Subjects
- *
INTIMATE partner violence , *SOCIAL problems , *PUBLIC health , *CROSS-sectional method , *RANDOMIZED controlled trials , *MENTAL illness prevention , *PSYCHIATRIC epidemiology , *MENTAL illness , *COMPARATIVE studies , *FAMILIES , *INTERPERSONAL relations , *INTERVIEWING , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *RESEARCH funding , *WOMEN'S health services , *EVALUATION research , *DISEASE prevalence , *SEXUAL partners , *PSYCHOLOGY - Abstract
Background: Intimate partner violence (IPV) is recognised as an important public health and social problem, with far reaching consequences for women's physical and emotional health and social well-being. Furthermore, controlling behaviour by a partner has a similar impact on women's well-being, yet little is known about the prevalence of this type of behaviour and other related abuses in Tanzania and in other sub-Saharan African countries.Methods: We conducted a cross-sectional study to determine the lifetime and past 12-month prevalence of physical and sexual IPV, economic abuse, emotional abuse and controlling behaviour among ever-partnered women in Mwanza, Tanzania. Women (N = 1049) were enrolled in an ongoing trial (Maisha study) to assess the impact of microfinance combined with gender training on participants' experience IPV, and other related outcomes. Interviews were conducted by same sex interviewers to collect information about socio-demographic characteristics, experiences of specific acts of IPV and abuse, and symptoms of poor mental health status.Results: Overall, about 61% of women reported ever experiencing physical and/or sexual IPV (95% CI: 58-64%) and 27% (95% CI: 24-29%) experienced it in the past 12 months. Partner controlling behaviour was the most prevalent type of abuse with 82% experiencing it in their lifetime and 63% during the past 12 months. Other types of abuses were also common, with 34% of women reporting economic abuse and 39% reporting emotional abuse during the past 12 months. The prevalence of IPV and abuses varied by socio-demographic characteristics, showing much higher prevalence rates among younger women, women with young partners and less educated women. After we adjusted for age and socio-economic status, physical violence (OR = 1.8; 95% CI: 1.3-2.7) and sexual violence (OR = 2.8; 95% CI: 1.9-4.1) were associated with increased reporting of symptoms of poor mental health. Similarly, experience of abuse during the past 12 months was associated with increased reporting of symptoms of poor mental health.Conclusions: The high prevalence of IPV and abuses and its strong links with symptoms of poor mental health underline the urgent need for developing and testing appropriate interventions in settings like Tanzania to tackle both violence and abusive behaviours among intimate partners.Trial Registration: ClinicalTrials.gov - ID NCT02592252 , registered retrospectively on 13 August 2015. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
18. Dysglycemia associations with adipose tissue among HIV-infected patients after 2 years of antiretroviral therapy in Mwanza: a follow-up cross-sectional study.
- Author
-
PrayGod, George, Changalucha, John, Kapiga, Saidi, Peck, Robert, Todd, Jim, and Filteau, Suzanne
- Subjects
DIAGNOSIS of diabetes ,HIV-positive persons ,HIGHLY active antiretroviral therapy ,BODY composition ,ANTHROPOMETRY ,PUBLIC health ,ANTI-HIV agents ,ADIPOSE tissues ,BLOOD sugar ,HUMAN body composition ,C-reactive protein ,DIABETES ,GLUCOSE tolerance tests ,HIV infections ,BIOELECTRIC impedance ,LONGITUDINAL method ,OBESITY ,PREDIABETIC state ,RESEARCH funding ,BODY mass index ,CROSS-sectional method ,GLUCOSE intolerance ,WAIST circumference - Abstract
Background: Data on the burden of dysglycemia among HIV-infected patients on antiretroviral therapy (ART) in Africa are limited. We determined the prevalence of pre-diabetes and diabetes among HIV-infected patients who started ART when malnourished 2 to 3 years previously and investigated the association of dysglycemia with body composition.Methods: Malnourished (body mass index (BMI) < 18.5 kg/m2) HIV-infected patients who were enrolled in the Nutritional Support for Africans Starting Antiretroviral Therapy (NUSTART) trial from 2011 to 2013 were followed-up from March to August 2015. Anthropometric, fat mass and fat-free mass by bioelectrical impedance, and C-reactive protein (CRP) data were collected at baseline and follow-up. At follow-up, we defined fasting glucose of 6.1-6.9 mmol/L as impaired fasting glucose (IFG) and 2-h oral glucose tolerance test (OGTT) glucose of ≥7.8 to <11.1 mmol/L as impaired glucose tolerance (IGT). Both of these were considered pre-diabetes. Fasting glucose of ≥7.0 mmol/L or impaired glucose tolerance of ≥11.1 mmol/L was defined as diabetes mellitus. The relation of pre-diabetes and diabetes with body composition was assessed using logistic regression.Results: Two hundred seventy-three (57%) of 478 patients who were alive at trial conclusion were followed-up. The mean age was 41.5 (SD 9.8) years and 65.2% (178) were females. The mean follow-up BMI was 19.9 (SD 2.8) kg/m2, 12 (4.4%) were either overweight or obese, and 61 (22.3%) patients had pre-diabetes or diabetes. In multiple regression, upper tertiles of baseline hip circumference (OR: 0.41, 95% CI: 0.2, 0.8) and fat mass index (OR: 0.20 (0.1, 0.5), and upper tertiles of follow-up waist circumference (OR: 0.22 (0.1, 0.5), BMI (OR: 0.32 (0.1, 0.7), fat mass index (OR: 0.19 (0.1, 0.5) and the middle tertile of follow-up fat-free mass (OR: 0.36, 95% CI: 0.1, 0.8) were associated with lower risk of pre-diabetes and diabetes (P < 0.05 for all). Baseline and follow-up CRP were not predictors.Conclusions: Low rather than high measures of adipose tissue were associated with increased risk of pre-diabetes and diabetes. Additional studies are needed to further investigate the role of body composition and control of glucose metabolism in the pathogenesis of diabetes among persons living with HIV in Africa. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
19. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda.
- Author
-
Kavishe, Bazil, Biraro, Samuel, Baisley, Kathy, Vanobberghen, Fiona, Kapiga, Saidi, Munderi, Paula, Smeeth, Liam, Peck, Robert, Mghamba, Janneth, Mutungi, Gerald, Ikoona, Eric, Levin, Jonathan, Bou Monclús, Maria Assumpció, Katende, David, Kisanga, Edmund, Hayes, Richard, and Grosskurth, Heiner
- Subjects
NON-communicable diseases ,DISEASE prevalence ,HYPERTENSION risk factors ,DIABETES risk factors ,HEART failure risk factors ,OBSTRUCTIVE lung diseases ,HIV infection risk factors ,DISEASE risk factors - Abstract
Background: The burden of non-communicable diseases (NCDs) is increasing in sub-Saharan Africa, but data available for intervention planning are inadequate. We determined the prevalence of selected NCDs and HIV infection, and NCD risk factors in northwestern Tanzania and southern Uganda. Methods: A population-based cross-sectional survey was conducted, enrolling households using multistage sampling with five strata per country (one municipality, two towns, two rural areas). Consenting adults (≥18 years) were interviewed using the WHO STEPS survey instrument, examined, and tested for HIV and diabetes mellitus (DM). Adjusting for survey design, we estimated population prevalences of hypertension, DM, obstructive pulmonary disease, cardiac failure, epilepsy and HIV, and investigated factors associated with hypertension using logistic regression. Results: Across strata, hypertension prevalence ranged from 16 % (95 % confidence interval (CI): 12 % to 22 %) to 17 % (CI: 14 % to 22 %) in Tanzania, and from 19 % (CI: 14 % to 26 %) to 26 % (CI: 23 % to 30 %) in Uganda. It was high in both urban and rural areas, affecting many young participants. The prevalence of DM (1 % to 4 %) and other NCDs was generally low. HIV prevalence ranged from 6 % to 10 % in Tanzania, and 6 % to 12 % in Uganda. Current smoking was reported by 12 % to 23 % of men in different strata, and 1 % to 3 % of women. Problem drinking (defined by Alcohol Use Disorder Identification Test criteria) affected 6 % to 15 % men and 1 % to 6 % women. Up to 46 % of participants were overweight, affecting women more than men and urban more than rural areas. Most patients with hypertension and other NCDs were unaware of their condition, and hypertension in treated patients was mostly uncontrolled. Hypertension was associated with older age, male sex, being divorced/widowed, lower education, higher BMI and, inversely, with smoking. Conclusions: The high prevalence of NCD risk factors and unrecognized and untreated hypertension represent major problems. The low prevalence of DM and other preventable NCDs provides an opportunity for prevention. HIV prevalence was in line with national data. In Tanzania, Uganda and probably elsewhere in Africa, major efforts are needed to strengthen health services for the PREVENTION, early detection and treatment of chronic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
20. Daily Acyclovir to Decrease Herpes Simplex Virus Type 2 (HSV-2) Transmission from HSV-2/HIV-1 Coinfected Persons: A Randomized Controlled Trial.
- Author
-
Mujugira, Andrew, Magaret, Amalia S., Celum, Connie, Baeten, Jared M., Lingappa, Jairam R., Morrow, Rhoda Ashley, Fife, Kenneth H., Delany-Moretlwe, Sinead, de Bruyn, Guy, Bukusi, Elizabeth A., Karita, Etienne, Kapiga, Saidi, Corey, Lawrence, and Wald, Anna
- Subjects
ACYCLOVIR ,HERPES simplex prevention ,DISEASE incidence ,RANDOMIZED controlled trials ,INFECTIOUS disease transmission ,MEDICAL statistics - Abstract
Background. Daily suppressive therapy with valacyclovir reduces risk of sexual transmission of herpes simplex virus type 2 (HSV-2) in HSV-2–serodiscordant heterosexual couples by 48%. Whether suppressive therapy reduces HSV-2 transmission from persons coinfected with HSV-2 and human immunodeficiency virus type 1 (HIV-1) is unknown.Methods. Within a randomized trial of daily acyclovir 400 mg twice daily in African HIV-1 serodiscordant couples, in which the HIV-1–infected partner was HSV-2 seropositive, we identified partnerships in which HIV-1–susceptible partners were HSV-2 seronegative to estimate the effect of acyclovir on risk of HSV-2 transmission.Results. We randomly assigned 911 HSV-2/HIV-1–serodiscordant couples to daily receipt of acyclovir or placebo. We observed 68 HSV-2 seroconversions, 40 and 28 in acyclovir and placebo groups, respectively (HSV-2 incidence, 5.1 cases per 100 person-years; hazard ratio [HR], 1.35 [95% confidence interval, .83–2.20]; P = .22). Among HSV-2–susceptible women, vaginal drying practices (adjusted HR, 44.35; P = .004) and unprotected sex (adjusted HR, 9.91; P = .002) were significant risk factors for HSV-2 acquisition; having more children was protective (adjusted HR, 0.47 per additional child; P = .012). Among HSV-2–susceptible men, only age ≤30 years was associated with increased risk of HSV-2 acquisition (P = .016).Conclusions. Treatment of African HSV-2/HIV-1–infected persons with daily suppressive acyclovir did not decrease risk of HSV-2 transmission to susceptible partners. More-effective prevention strategies to reduce HSV-2 transmission from HIV-1–infected persons are needed. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
- Full Text
- View/download PDF
21. Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10–25-Year-Old HIV-Seronegative African Girls and Young Women.
- Author
-
Sow, Papa Salif, Watson-Jones, Deborah, Kiviat, Nancy, Changalucha, John, Mbaye, Khardiata Diallo, Brown, Joelle, Bousso, Kouro, Kavishe, Bazil, Andreasen, Aura, Toure, Macoumba, Kapiga, Saidi, Mayaud, Philippe, Hayes, Richard, Lebacq, Marie, Herazeh, Marjan, Thomas, Florence, and Descamps, Dominique
- Subjects
HUMAN papillomavirus vaccines ,VACCINE safety ,CERVICAL cancer ,AFRICANS ,HIV infections ,PUBLIC health ,YOUNG women ,DISEASES - Abstract
Background. Cervical cancer is a major public health problem for women in sub-Saharan Africa. Availability of a human papillomavirus (HPV) vaccine could have an important public health impact.Methods. In this phase IIIb, double-blind, randomized, placebo-controlled, multicenter trial (NCT00481767), healthy African girls and young women seronegative for human immunodeficiency virus (HIV) were stratified by age (10–14 or 15–25 years) and randomized (2:1) to receive either HPV-16/18 AS04-adjuvanted vaccine (n = 450) or placebo (n = 226) at 0, 1, and 6 months. The primary objective was to evaluate HPV-16/18 antibody responses at month 7. Seropositivity rates and corresponding geometric mean titers (GMTs) were measured by enzyme-linked immunosorbent assay.Results. In the according-to-protocol analysis at month 7, 100% of initially seronegative participants in the vaccine group were seropositive for both anti–HPV-16 and anti–HPV-18 antibodies (n = 130 and n = 128 for 10–14-year-olds, respectively; n = 190 and n = 212 for 15–25-year-olds). GMTs for HPV-16 and HPV-18 were higher in 10–14-year-olds (18 423 [95% confidence interval, 16 185–20 970] and 6487 [5590–7529] enzyme-linked immunosorbent assay units (EU)/mL, respectively) than in 15–25-year-olds (10 683 [9567–11 930] and 3743 [3400–4120] EU/mL, respectively). Seropositivity was maintained at month 12. No participant withdrew owing to adverse events. No vaccine-related serious adverse events were reported.Conclusions. The HPV-16/18 AS04-adjuvanted vaccine was highly immunogenic and had a clinically acceptable safety profile when administered to healthy HIV-seronegative African girls and young women. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
22. Plasma Viral Loads During Early HIV-1 Infection Are Similar in Subtype C– and Non-Subtype C–Infected African Seroconverters.
- Author
-
Campbell, Mary S., Kahle, Erin M., Celum, Connie, Lingappa, Jairam R., Kapiga, Saidi, Mujugira, Andrew, Mugo, Nelly R., Fife, Kenneth H., Mullins, James I., and Baeten, Jared M.
- Subjects
HIV infections ,VIRAL load ,BLOOD plasma ,HIV seroconversion ,AFRICANS ,VIREMIA ,DISEASES - Abstract
Recent data suggest that infection with human immunodeficiency virus type 1 (HIV-1) subtype C results in prolonged high-level viremia (>5 log10 copies/mL) during early infection. We examined the relationship between HIV-1 subtype and plasma viremia among 153 African seroconverters. Mean setpoint viral loads were similar for C and non-C subtypes: 4.36 vs 4.42 log10 copies/mL (P = .61). The proportion of subtype C–infected participants with viral loads >5 log10 copies/mL was not greater than the proportion for those with non-C infection. Our data do not support the hypothesis that higher early viral load accounts for the rapid spread of HIV-1 subtype C in southern Africa. [ABSTRACT FROM PUBLISHER]
- Published
- 2013
23. Pathways of romantic jealousy to intimate partner violence in Mwanza, northern Tanzania.
- Author
-
Aloyce, Diana, Mshana, Gerry, Peter, Esther, Malibwa, Donati, Buller, Ana Maria, Mchome, Zaina, Kapiga, Saidi, and Stöckl, Heidi
- Subjects
- *
VIOLENCE against women , *INTIMATE partner violence , *SEXUAL partners , *JEALOUSY , *MASCULINITY - Abstract
Objective: The goal of this research is to establish the pathways through which romantic jealousy leads to intimate partner violence. Background: Physical and/or sexual intimate partner violence is widespread, with one in four women reporting it globally. Romantic jealousy is a known risk factor for intimate partner violence, yet little is known about the pathways that link it to intimate partner violence, especially in Africa. Method: We used a qualitative design, interviewing 18 adult women in Northern Tanzania to understand their experiences and reflections of intimate partner violence. To grasp the mechanisms through which jealousy can trigger intimate partner violence, our analysis utilizes the concept of hegemonic masculinity. Results: Intimate partner violence and romantic jealousy emerged as major issues in women's lives in this study. We established six pathways linking these variables: women confronting their partners because of infidelity, partners' anger because women confronted their mistress, women refusing to have sex or talk with their partners because they were jealous, male partners failing to control or regulate their emotions and becoming violent, and men feeling that their masculinity is threatened. Conclusion: In this study, intimate partner violence against women was largely men's reaction to their interpretation of perceived triggers of romantic jealousy and emotions as a threat to their masculinity and dominance. Implications: Interventions aiming to prevent intimate partner violence need to address the pathways linking the violence to romantic jealousy and include this connection in their programming. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania
- Author
-
Quentin, Wilm, Terris-Prestholt, Fern, Changalucha, John, Soteli, Selephina, Edmunds, W. John, Hutubessy, Raymond, Ross, David A., Kapiga, Saidi, Hayes, Richard, and Watson-Jones, Deborah
- Subjects
uterine cervical neoplasms ,Africa ,economics papillomavirus vaccines ,610 Medizin und Gesundheit ,costs and cost analysis ,health care economics and organizations ,3. Good health - Abstract
Background: Cervical cancer is the leading cause of female cancer-related deaths in Tanzania. Vaccination against human papillomavirus (HPV) offers a new opportunity to control this disease. This study aimed to estimate the costs of a school-based HPV vaccination project in three districts in Mwanza Region (NCT ID: NCT01173900), Tanzania and to model incremental scaled-up costs of a regional vaccination program. Methods: We first conducted a top-down cost analysis of the vaccination project, comparing observed costs of age-based (girls born in 1998) and class-based (class 6) vaccine delivery in a total of 134 primary schools. Based on the observed project costs, we then modeled incremental costs of a scaled-up vaccination program for Mwanza Region from the perspective of the Tanzanian government, assuming that HPV vaccines would be delivered through the Expanded Programme on Immunization (EPI). Results: Total economic project costs for delivering 3 doses of HPV vaccine to 4,211 girls were estimated at about US$349,400 (including a vaccine price of US$5 per dose). Costs per fully-immunized girl were lower for class-based delivery than for age-based delivery. Incremental economic scaled-up costs for class-based vaccination of 50,290 girls in Mwanza Region were estimated at US$1.3 million. Economic scaled-up costs per fully-immunized girl were US$26.41, including HPV vaccine at US$5 per dose. Excluding vaccine costs, vaccine could be delivered at an incremental economic cost of US$3.09 per dose and US$9.76 per fully-immunized girl. Financial scaled-up costs, excluding costs of the vaccine and salaries of existing staff were estimated at US$1.73 per dose. Conclusions: Project costs of class-based vaccination were found to be below those of age-based vaccination because of more eligible girls being identified and higher vaccine uptake. We estimate that vaccine can be delivered at costs that would make HPV vaccination a very cost-effective intervention. Potentially, integrating HPV vaccine delivery with cost-effective school-based health interventions and a reduction of vaccine price below US$5 per dose would further reduce the costs per fully HPV-immunized girl.
25. The Role of Structural Factors in Support-Seeking Among Women Experiencing Intimate Partner Violence (IPV) in Mwanza, Tanzania: Findings From a Qualitative Study.
- Author
-
Selestine, Veronica, Harvey, Sheila, Mshana, Gerry, Kapiga, Saidi, and Lees, Shelley
- Subjects
- *
VIOLENCE & psychology , *PSYCHOLOGY of abused women , *HEALTH services accessibility , *FOCUS groups , *HUMAN research subjects , *SOCIAL support , *STAKEHOLDER analysis , *HELP-seeking behavior , *PATIENT-centered care , *INTERVIEWING , *DOMESTIC violence , *FEAR , *SOCIAL stigma , *VIOLENCE , *EXPERIENCE , *SOCIOECONOMIC factors , *QUALITATIVE research , *INFORMED consent (Medical law) , *COMPARATIVE studies , *CONCEPTUAL structures , *GENDER identity , *GENDER , *INTIMATE partner violence , *DESCRIPTIVE statistics , *RELIGIOUS leaders , *SOUND recordings , *ADULTERY , *CHILD welfare , *QUALITY of life , *RESEARCH funding , *SOCIODEMOGRAPHIC factors , *DATA analysis software , *HEALTH equity , *NEEDS assessment , *LONGITUDINAL method , *RELIGION , *DEPENDENCY (Psychology) - Abstract
In this qualitative study of women participating in an intimate partner violence (IPV) prevention trial, experiences of IPV and the context that shapes support-seeking were explored through in-depth interviews and focus groups discussions. Decisions to seek support were influenced by a range of factors including fear of further abuse, shame, acceptance of IPV as normal, belief that IPV is a private matter between the couple, economic dependence on male partners, and a poorly responsive legal and justice system. Gender empowerment programs need to intervene at the social, cultural, political, and economic levels that shape justification and meanings attached to IPV and women's decisions in seeking support. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. FEM-PrEP.
- Author
-
Corneli, Amy L., Deese, Jennifer, Wang, Meng, Taylor, Doug, Ahmed, Khatija, Agot, Kawango, Lombaard, Johan, Manongi, Rachel, Kapiga, Saidi, Kashuba, Angela, and Van Damme, Lut
- Abstract
Several clinical trials have demonstrated the safety and effectiveness of oral tenofovir disoproxil fumarate (TDF), with or without emtricitabine (FTC), as pre-exposure prophylaxis (PrEP) for reducing the risk of HIV acquisition. Adherence to the study product was insufficient to demonstrate the effectiveness of FTC/TDF in 2 PrEP clinical trials conducted among women (FEM-PrEP and the Vaginal and Oral Interventions to Control the Epidemic study), but further analyses of adherence in these studies may inform PrEP demonstration projects and future HIV prevention clinical trials.We randomly selected a subcohort of 150 participants randomized to FTC/TDF in 3 FEM-PrEP sites (Bondo, Kenya; Bloemfontein, South Africa; and Pretoria, South Africa) to examine adherence levels over time and to assess factors associated with adherence, based on plasma tenofovir and intracellular tenofovir diphosphate drug concentrations in specimens collected at 4-week visit intervals.We observed drug concentrations consistent with good adherence in 28.5% of all visit intervals when drug was available to use, but only 12% of participants achieved good adherence throughout their study participation. In multivariate analysis, the Bloemfontein site [odds ratio (OR): 2.43; 95% confidence interval (CI): 1.32 to 4.48] and liking the pill color (OR: 2.93; 95% CI: 1.18 to 7.27) were positively associated with good adherence, whereas using oral contraceptive pills at enrollment was negatively associated with good adherence (OR: 0.37; 95% CI: 0.18 to 0.74).Most participants did not regularly adhere to the study product throughout their trial participation, although a small minority did. Few factors associated with good adherence to the study product were identified in FEM-PrEP. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
27. Masculinity, power and structural constraints: Men's conceptualization of emotional abuse in Mwanza, Tanzania.
- Author
-
Mshana, Gerry, Peter, Esther, Malibwa, Donati, Aloyce, Diana, Kapiga, Saidi, and Stöckl, Heidi
- Subjects
- *
INTIMATE partner violence , *MASCULINITY , *PSYCHOLOGICAL abuse , *PSYCHOLOGY of men , *INTERVIEWING , *FIELDWORK (Educational method) , *POWER (Social sciences) , *PSYCHOLOGICAL factors - Abstract
Intimate partner violence is a global problem with devastating social and health consequences to individuals and families. While some forms of intimate partner violence such as physical and sexual violence have been explored in depth, there is a lack of clarity on men's perspectives of emotional violence, particularly in low-income countries. Yet it is recognized that incorporating men's perspectives and participation is crucial for addressing intimate partner violence. We draw from in-depth interviews with 30 men and 1, 645 pictures collected through photo voice to explore men's conceptualization and experiences of emotional violence by female partners in Mwanza, Tanzania. A sub-sample of the men (n = 16) were interviewed for a second time about pictures showing different aspects of their lives. The fieldwork was conducted between April and December 2019, and the data were analyzed through a multistage inductive process. Participants described emotional violence through a narrative of ' being hurt' by some actions or words of their partners. These included: verbal complaints about failure to provide for family, partner's infidelity and flirting with other men, accusation of poor sexual performance, and perceived normative deviance characterized by coming home late and not carrying out domestic chores. Threatened masculinities drawing from negative communal normative ideals, and the underlying interpersonal power struggles with their partners for the control of economic provision, sexual intimacy and family matters framed men's definitions of emotional violence. Ongoing changes such as women's ownership and engagement in economic activities and the scarcity of employment opportunities for men challenges their household dominance. Multicomponent interventions should target men, couples and communal ideals reinforcing negative masculinity. Analysis of interpersonal power and structural dynamics influencing relationships must inform the design of interventions instead of the narrow focus on individual demographic attributes. • Male perspectives and engagement crucial for addressing intimate partner violence. • Lack of insight on female to male emotional violence in low-income contexts. • Threatened masculinities underlie men's perspectives of emotional violence. • Socio-economic and policy circumstances influencing power dynamics in relationships. • Tackling both individual and structural factors key to addressing partner violence. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.